NasdaqCM - Nasdaq Real Time Price • USD
Aspira Women's Health Inc. (AWH)
As of 11:44 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.34 | -0.31 | -1.34 | -1.03 |
| Low Estimate | -0.37 | -0.37 | -1.55 | -1.4 |
| High Estimate | -0.28 | -0.25 | -1.2 | -0.84 |
| Year Ago EPS | -0.73 | -0.28 | -1.81 | -1.34 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 2.41M | 2.75M | 10.97M | 19.67M |
| Low Estimate | 2.1M | 2.6M | 10.7M | 13.34M |
| High Estimate | 2.73M | 2.94M | 11.2M | 29.7M |
| Year Ago Sales | 2.32M | 2.49M | 9.15M | 10.97M |
| Sales Growth (year/est) | 4.10% | 10.40% | 19.80% | 79.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.75 | -0.55 | -0.51 | -0.45 |
| EPS Actual | -0.73 | -0.28 | -0.48 | -0.3 |
| Difference | 0.02 | 0.27 | 0.03 | 0.15 |
| Surprise % | 2.70% | 49.10% | 5.90% | 33.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.34 | -0.31 | -1.34 | -1.03 |
| 7 Days Ago | -0.34 | -0.31 | -1.34 | -1.03 |
| 30 Days Ago | -0.3 | -0.29 | -1.39 | -1.24 |
| 60 Days Ago | -0.3 | -0.29 | -1.39 | -1.24 |
| 90 Days Ago | -0.28 | -0.27 | -1.47 | -1.69 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AWH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 53.40% | -- | -- | 1.50% |
| Next Qtr. | -10.70% | -- | -- | 11.40% |
| Current Year | 26.00% | -- | -- | 5.20% |
| Next Year | 23.10% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 4/10/2024 |
| Maintains | Cantor Fitzgerald: Neutral to Neutral | 4/1/2024 |
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 9/26/2023 |
| Initiated | Alliance Global Partners: Buy | 8/22/2023 |
| Maintains | Cantor Fitzgerald: Neutral to Neutral | 5/17/2023 |
Related Tickers
BDSX Biodesix, Inc.
1.2461
-1.10%
CORBF Global Cord Blood Corporation
1.2300
-8.89%
XGN Exagen Inc.
1.3900
+1.46%
PMD Psychemedics Corporation
2.5700
-4.00%
FONR FONAR Corporation
16.49
+1.85%
ENZ Enzo Biochem, Inc.
1.0500
-0.95%
NDRA ENDRA Life Sciences Inc.
0.2401
-7.62%
PRE Prenetics Global Limited
4.8816
+1.91%
ACRS Aclaris Therapeutics, Inc.
1.1600
-0.85%
DRIO DarioHealth Corp.
1.4700
-2.00%